Cognitive functioning in children and adolescents with multiple sclerosis.
about
Multiple sclerosis in the very young: a case report and review of the literature.Cognitive changes in multiple sclerosis.Cortical pathology and cognitive impairment in multiple sclerosis.Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.Cognitive dysfunction in pediatric multiple sclerosis.A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosusNeurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institutionLongitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.Therapeutic strategies in childhood multiple sclerosisWork capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination.Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis.Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.Neuropsychiatric manifestations of multiple sclerosis.Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.Disease-modifying therapy of pediatric multiple sclerosis.Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosisManagement of multiple sclerosis in adolescents - current treatment options and related adherence issues.Cognitive impairment in pediatric multiple sclerosis.Therapies for multiple sclerosis: considerations in the pediatric patient.Management of children with multiple sclerosis.Rehabilitation interventions in multiple sclerosis: an overview.The management of pediatric multiple sclerosis.Pathogenesis of pediatric multiple sclerosis.Neuropsychological correlates of multiple sclerosis across the lifespan.Physical activity and pediatric multiple sclerosis: Developing a research agenda.Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.Psychiatric disorders in children with demyelinating diseases of the central nervous system.Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?Neuropsychological outcomes of pediatric demyelinating diseases: a review.Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.International Pediatric MS Study Group Clinical Trials Summit: meeting report.Psychiatric comorbidity in pediatric patients with demyelinating disorders.Age of onset as a moderator of cognitive decline in pediatric-onset multiple sclerosis.Fatigue and quality of life in pediatric multiple sclerosis.The management of multiple sclerosis in children: a European view.Fatigue and depression in children with demyelinating disorders.Multiple sclerosis in childhood: clinical and radiological features.
P2860
Q31037769-3EFE793C-9B88-45A2-B7A4-48D68BDDC94AQ33377548-56F680EC-0DDD-4F88-A115-DB48E1A2379DQ33837296-C5084DAC-86C9-4EC6-BA84-CDE75FF554E3Q33837301-D3B0740F-A5CB-4AFB-9366-19BF7D757171Q33968709-33F512B0-4CF8-40E6-83FA-91B069A9B556Q34114987-2BFF02C8-9F19-4FAA-BB08-8A2994F5B3A9Q34307491-25F386E7-4324-4E7A-9C0D-FFB0E1B1982CQ34315953-0544C940-381B-4B4E-9DBE-D4ED3EFC8C17Q34409508-8FD3C2C0-4E70-49DE-98C1-38FF2354185FQ34623131-6C23D5B4-74FA-4002-8959-91FCF492DC2EQ34799719-EAC35629-DF7E-42D2-AA62-8F049B48E94CQ35041978-12337E3D-A0CA-420E-87B9-7E3D825F432FQ36064719-AF1267E3-43B7-4FDD-8E99-C059DB6BDB60Q36413401-C3C74BD9-7111-4A8A-85D3-A78D86A7830CQ36474339-E03C6AAE-D8C6-465E-B551-F149C7CA0819Q36537583-95F1E2F1-EDA1-4649-9D5B-4980A2A9AE41Q36568645-785C79F0-C5F9-4004-B1C9-6DCB607E2A44Q36839814-FC3B2D1E-1BA8-44EC-8959-ECA65B8A1033Q37481523-F007E63D-0617-443F-8416-F98B28DE4B83Q37562003-6C43163A-B2D7-4388-AA23-A98754E3EB69Q37799568-D860567C-A973-4DDC-8843-A7936294E64EQ37827690-95A2B07A-63D2-44C5-91C9-A962EC06BF82Q38002113-433CC699-E7F9-4272-BCDB-BC3537A8483CQ38024650-2CC29B90-2A1D-4849-9A85-45A422315750Q38036853-C1FE8285-FB5A-4DD4-ABDD-D12994C4360DQ38041081-0C4971FF-29BA-46D8-B715-3E0D6AFF8A64Q38545084-DCD1C7F4-EE02-41B6-A2E4-D11C82671882Q38602040-2F335E07-F4C7-4134-A6B6-F0702C8091F3Q38632953-E7B9BABC-CAA9-4F2C-92A2-6A48CAD0D2C6Q38694282-7130A246-0C3F-4BB8-B960-1E991CF4DDEEQ39191862-4FC45264-643D-4ED2-907A-9C1AC2784A86Q39388520-0A848CA8-DB5A-4216-90C8-FB04BB146876Q40143991-A8B4F446-A113-4D2A-814F-AAA7253354C7Q43152753-F9D08126-D54A-4E00-B989-BF0F6FB2CCECQ43769945-E6F0F087-072E-41BD-BC1A-2E3CE6C0A125Q44098570-BEC7AA3E-F8B0-49F6-AFDB-07A055C399A9Q44625623-4CAA9576-FC86-44F7-B71E-8A30D1C2CE37Q45108726-71E229E6-D5B5-4BF6-9B9E-4C589A7566A2Q46182973-6E103C98-AC32-4BFD-B82F-B68FD895868FQ46305250-7E890A19-2B5E-4F29-A331-822B4A81DACF
P2860
Cognitive functioning in children and adolescents with multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cognitive functioning in children and adolescents with multiple sclerosis.
@en
Cognitive functioning in children and adolescents with multiple sclerosis.
@nl
type
label
Cognitive functioning in children and adolescents with multiple sclerosis.
@en
Cognitive functioning in children and adolescents with multiple sclerosis.
@nl
prefLabel
Cognitive functioning in children and adolescents with multiple sclerosis.
@en
Cognitive functioning in children and adolescents with multiple sclerosis.
@nl
P2093
P1433
P1476
Cognitive functioning in children and adolescents with multiple sclerosis.
@en
P2093
Christodoulou C
Cianciulli C
MacAllister WS
Preston TE
Weisbrot DM
P304
P356
10.1212/01.WNL.0000158474.24191.BC
P407
P577
2005-04-01T00:00:00Z